can block SCF binding to cell surface c-kit receptors. These results suggest that the soluble c-kit receptor may play a role in regulating c-kit activation in vivo.
MATERIALS AND METHODS

Cytokines.
Purified recombinant human SCF expressed in Escherichia coli was provided by Amgen (Thousand Oaks, CA). Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was expressed in BHK cells and was provided by Dr Kenneth Kaushansky (University of Washington, Seattle, WA). Recombinant human interleukin-3 (IL-3) was obtained from Genetics Institute (Cambridge, MA). Recombinant human erythropoietin (Epo) was expressed in BHK cells."
Recombinant soluble c-kit receptor. Recombinant soluble c-kit receptor was produced by Chinese hamster ovary (CHO) cells transfected with plasmid pDSRa-HuSKit14 encoding the A+ isoform of c-kit that contains the 12-bp sequence (encoding Gly Asn Asn Lys) in the extracellular domain of the molec~le.'~ The c-kit insert was generated by polymerase chain reaction (PCR) amplification of mRNA from HEL cells using 5'-GGA GTC TAG ACC ATG AGA TGT GGG GAT GGA TIT G-3'. The amplified product was digested with Xba I and Sal I and inserted into the expression vector ~D S R O~. '~ C H 0 cell clones expressing soluble c-kit were generated by calcium phosphate-mediated transfection and selected based on the level of c-kit message expressed. C H 0 cells were grown in roller bottles using serum-free Dulbecco's modified Eagle's medium (DMEM)-Ham's F12 media (50:50 mixture; GIBCO, Grand Island, NY) supplemented with nonessential amino acids. Three harvests of conditioned media containing soluble c-kit protein were collected at 5-to 7-day intervals and pooled for purification.
Purification of soluble c-kit receptor. Soluble c-kit receptor was purified by affinity chromatography using immobilized SCF. TWO affinity chromatography methods were used. Similar results were obtained with both preparations of purified recombinant c-kir receptor. Initially, conditioned medium from CH0 cells expressing soluble c-kit was concentrated and dialyzed with phosphate-buffered saline (PBS) using a 30-kD molecular weight cut off membrane (SlY30; Amicon, Danvers, MA). The concentrate was applied directly to a column of immobilized SCF, coupled at 1 mg SCF per milliliter of resin (CNBr-activated Sepharose; Pharmacia, Piscataway, NJ). The column was washed with PBS and then eluted with 0.5 m o m NaCL 50 mmoVL sodium acetate, pH 4.0. Analysis of the elution pool by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; Novex, Encinitas, CA) indicated that the purity of the soluble GGC GCT CGC GG-3' and 5"CCT CCG CGG TCG ACT AGG In subsequent experiments, purified recombinant human SCF was coupled to Actigel ALD Superflow (Sterogene Bioseparations, Inc, St Arcadia, CA) at a ratio of 10 mg SCF to 5 mL Actigel, according to manufacturer's directions. After coupling, the gel was washed extensively with ActiSep Elution Medium (Sterogene) and then with 4 moVL NaSCN, 50 mmoVL acetate buffer (pH 4) to insure that unbound SCF was removed from the gel. The SCF affinity gel was finally washed and equilibrated with PBS. Human serum and conditioned media containing soluble c-kit produced by the OCIMl cells or by transfected C H 0 cells were concentrated 25-fold in an Amicon stirred cell ultrafiltration unit over a Y"10 membrane. The concentrate was added to the SCF-Actigel and the slurry was rocked overnight at 4°C to 8°C. The concentrate was drained and the gel bed was washed with PBS until the OD 280 MI absorbance of the wash was less than 0.01 absorbance units, The c-kif bound to the SCFActigel was then eluted with ActiSep Elution Medium. The eluate was dialyzed extensively with PBS and concentrated by ultrafiltration over an Amicon Y " I 0 membrane. The concentrate was sterile filtered and aliquots were quantitatively assayed for SCF and for ckif by enzyme immunoassay (EIA) as described below.
Cell lines. The factor-independent human erythroleukemia cell line, OCIMI, was maintained in Iscove's modified Dulbecco's medium (IMDM; GIBCO) supplemented with 10% calf serum (CS; Hyclone, Logan, UT).16 The SCF-responsive human megakaryoblastic cell line M07e"*" was maintained in IMDM supplemented with 10% fetal calf serum (FCS; Hyclone) and GM-CSF (3 ng/mL).
The Daudi cell line was grown in RPM1 1640 (M.A. Bioproducts, Walkersville, MD) supplemented with 10% FCS.I9 The HEL cell line was maintained in IMDM supplemented with 10% FCS.
Binding aflnity and quanfifation of c-kit receptors on OCIMI, M07e, and HEL cells. SCF was iodinated using the chloramine T method." The radiologic specific activity of '"I-SCF was determined by self-displacement analysis" and was approximately 2,000 Ci/ m o l . Iodination of SCF did not alter its biologic activity." The binding affinity and the number of c-kit receptors expressed on the surface of OCIh41, M07e, and HEL cells were determined by Scatchard analyses of equilibrium binding experiment^.^^^'^ The cells were incubated with varying amounts of '=I-SCF (10 pmoVL to 5 nmoVL) with or without a 100-fold excess of unlabeled SCF in binding buffe2' for 4 hours in a 15°C shaking water bath. At the conclusion of the incubation, the cells were separated from the media containing free "'I-SCF by sedimentation through phthalate oil (dibutyl phthalate:dinonyl phthalate 3.5:2.0). Cell-associated and free Iz5I were quantitated using a Packard 5330 gamma counter (Packard Instrument CO, Downers Grove, E). All measurements were performed in triplicate, and the data were analyzed using the ligand program." Soluble c-kit receptor binding studies. The binding affinity of the serum-derived, O C I M I , and recombinant soluble c-kit receptor was determined by incubating purified soluble c-kit receptor (2 nmoV L) with increasing concentrations of "'I-SCF (50 pmoVL to 7 nmoV L) with or without a 100-fold excess of unlabeled SCF in binding buffer. After an overnight incubation at 4°C. '251-SCF-c-kit receptor complexes were immunoprecipitated by the addition of 2 pL of polyclonal anti-c-kit antibody no, 1855 and 10 pL of protein ASepharose beads (Pharmacia LKB, Uppsala, Sweden) for 2 hours at 4°C. Antibody no. 1855 was raised by immunizing rabbits with the synthetic peptide SAYFNFAFKGNNKEQIHPHT, a sequence found at the C-terminus of the extracellular domain of the A+ i s o f~r m '~~~~ of c-kir. Binding studies were performed in parallel in which the 1Z51-SCF-c-kit receptor complexes were immunoprecipitated with polyclonal antibody no. 951-960 was obtained by immunizing rabbits with the A+ isoform of the human recombinant soluble c-kit receptor. The immunoprecipitates were washed twice with TNTG (20 mmoVL Tris [pH 7.51, 150 mmoVL NaCI, 0.1% Triton X-100, 10% glycerol). "'I-SCF bound to the soluble c-kit receptor was measured in the immunoprecipitates; free 1Z51-SCF was quantitated in the supernatant. Measurements were performed in duplicate, and the data were analyzed using the ligand pr~gram.'~ The ability of the native and the recombinant soluble c-kit receptor to block binding of IZ5I-SCF to cells was also evaluated. OCIMl cells (l@) were incubated with '"I-SCF (40 pmoVL) and increasing concentrations of affinity-purified OCIMl, serum-derived, or recombinant soluble c-kit receptor (50 pmoVL to 50 nmoVL) for 6 hours at 15°C. OCIMl cells incubated with '251-SCF in the absence of soluble c-kit receptor or with a 100-fold excess of unlabeled SCF served as a control.
AfJiniry cross-linking. To determine the molecular weight of the M07e and OCIMl cell surface c-kit receptor, we performed "'I-SCF cross-linking as previously described." Briefly, the cells (5 X lo6) were incubated with 1 nmoVL '"I-SCF for 4 hours at 15°C to saturate cell surface c-kit receptors. Cross-linking was performed by adding 1 mmoVL bis-sulfosuccinimidyl suberate (BS,; Pierce, Rockford, IL) and incubating for 30 minutes at 22°C. The reaction was terminated with 20 mmoVL Tris HCL (pH 7.6). The cells were washed and then lysed in buffer, as previously described. The cell lysates were spun at high speed to remove cellular debris. The receptor-ligand complexes were immunoprecipitated using polyclonal antihuman SCF antibodies (antibody no. 1334; Amgen) followed by incubation with protein A-Sepharose beads (Pharmacia LKB) for 3 hours at 4°C. The immunoprecipitates were washed once in TNTG, then resuspended in 2X sample buffer (0.125 mmol/L Tris HCI [pH 6.81, 4% SDS, 0.008% bromophenol blue, 20% glycerol), and subjected to electrophoresis on a 5% polyacrylamide gelz6 (SDS-PAGE).
The molecular weight of the OCIMl, serum, and recombinant soluble c-kit receptor was determined by "'I-SCF cross-linking as described above, except that 50 nmoVL of soluble receptor was incubated with 5 nmoVL 1251-SCF overnight at 4°C. The receptorligand complexes were crosslinked, immunoprecipitated, and analyzed by SDS-PAGE as described above.
EIA for soluble c-kit receptor. OCIM1, M07e, and HEL cells were washed twice in IMDM and resuspended in culture media at 7.5 X 10' cells/mL to test for the production of soluble c-kit receptors. Culture media conditioned by the three cell lines were collected at various intervals and tested for the presence of soluble c-kit receptor by EIA. The fraction of viable cells was greater than 95% for all samples. The EIA for soluble c-kit receptor was modified from a technique previously described." Media alone with 10% FCS 2 3 ng/mL GM-CSF as well as media conditioned by a cell line without detectable cell surface c-kit receptors (Daudi) were tested in parallel. The samples were concentrated fivefold using a centricon 10 microconcentrator (Amicon, Beverly, MA) before performing the EIA.
The EIA was performed using microtiter wells coated with an affinity-purified rabbit polyclonal anti-c-kit antibody no. 951-960. Purified recombinant soluble c-kit (amino acids 1-5 19) produced in CH0 cells was used to generate a standard curve. Recombinant human soluble c-kif or conditioned media (100 pL) were added to the wells and incubated for overnight at 22°C. For signal detection, the SR-1 anti-c-kit receptor monoclonal antibody" covalently coupled to horseradish peroxidase was added and the incubation was continued for 2 hours at 22°C. The wells were washed four times with 0.01% Tween 20 in 50 mmoVL Tris (pH 7.4), 150 mmoVL NaCI, 10 mmoV L EDTA, and 100 pL of TMB Microwell Peroxidase substrate solution (Kirkegaard and Perry Laboratories, Gaithersburg, MD) was added as previously described." The absorbance was read at 450 nmoVL using a Molecular Devices Vmax Kinetic Microplate Reader CS that had been dialyzed against PBS. The cells were incubated with 3'S-methionine/cysteine (100 pCi/mL; Dupont NEN, Wilmington, DE) for 1 hour at 37°C. The cells were washed and resuspended in IMDM with 2% FCS at a concentration of 1 X 106/mL. A sample of cells (2 X lo6) was removed at time 0 and at 30 minutes, 60 minutes, 2 hours, 5 hours, 10.5 hours, 22 hours, and 30 hours. The cells were lysed in lysis buffer" and SR-l antibody (1 pg/mL) was added to the lysates and incubated overnight at 4"C, followed by incubation with protein A-Sepharose beads. The beads were washed with TNTG, resuspended in 2X sample buffer, and subjected to electrophoresis on a 5% polyacrylamide gel. OCIMl conditioned media (20 mL) were collected at time 0 and at 5 hours, 10.5 hours, 22 hours, and 30 hours. The conditioned media were precleared with protein A-Sepharose beads for 2 hours at 4°C. SR-1 antibody (0.7 pg/mL) was added to half the volume of the conditioned media. An equivalent amount of isotype-matched control antibody (anti-Epo monoclonal antibody) was added to the remaining sample of conditioned media. Both samples were incubated overnight at 4°C. Protein A-Sepharose beads (50 pL of a 50% slurry) were added and the incubation was continued for 4 hours at 4°C. The immunoprecipitates were washed and analyzed by 5% SDS-PAGE.
RESULTS
Characterization of c-kit receptors on the OCIMl M07e and HEL cell surface. Equilibrium binding experiments showed that the OCIMl cells express a single class of highaffinity c-kit receptors (kd 210 rl: 52 pmoVL; mean t-SEM of 5 experiments) with approximately 80,000 receptors per cell (Fig 1) . Scatchard analysis of M07e binding data also showed a single class of c-kit receptors. There are approximately 35,000 c-kit receptors per M07e cell, with a kd of 150 t 42 pmoVL (mean 2 SEM of 3 experiments). Scatchard analysis of HEL binding data showed a single class of high-affinity receptors with a kd of 240 pmoVL and -38,000 receptors per HEL cell (average of 2 experiments; Table 1 ). To determine the molecular weight of the c-kit receptor, Iz5I-SCF was cross-linked to its receptor on the M07e cell surface using B&. The 'Z51-SCF/c-kit receptor complexes were precipitated with an anti-SCF polyclonal antibody and analyzed by SDS-PAGE. Two major bands, at 170 kD and 340 kD, were apparent (data not shown). After accounting for the contribution of the E coli-expressed recombinant SCF (18 kD), the molecular weight of the c-kit receptor in M07e cells is estimated to be 152 M), which is consistent with a previous report.
Detection of soluble c-kit receptors produced by OCIMl and M07e cells. To determine whether human hematopoietic cells can produce soluble c-kit receptors, we used two cell lines (OCIM1 and M07e) that display large numbers of high-affinity c-kit receptors on the cell surface. Media conditioned by the Daudi cell line, which does not express c-kit receptors on the cell surface,** was used as a control. The cells were washed twice and resuspended in fresh culture media. Conditioned media were collected after 24 to 96 hours of incubation and were tested for soluble c-kit receptors by EIA (Table 2) . Neither the media incubated in the absence of cells nor the Daudi conditioned media contained detectable soluble c-kit receptors. Soluble c-kit receptor was detected in M07e conditioned media as early as after 24 hours of incubation and increased over time (Table 2) .
SCF binding afJinity and molecular weight of the OCIMl, recombinant, and human serum-derived soluble c-kit receptors. The binding affinity of the soluble c-kit receptor was determined by equilibrium binding analysis. The OCIMl soluble c-kit receptor displayed high-affinity SCF binding (kd of -200 pmoVL), similar to the binding affinity of the transmembrane c-kit receptor (Fig 2) . Purified recombinant soluble c-kit receptor displayed a lower SCF binding affinity of 1 to 2 nmoVL ( Table 1 ). The kd was similar when immu- dicating that the lower binding affinity was not caused by the purification process.
Control media
Despite the fivefold to 10-fold difference in SCF binding affinity, native soluble c-kit receptors from OCIMl cells and human serum and recombinant soluble c-kit receptors were found to be of similar molecular weight by '"I-SCF affinity cross-linking. When '"I-SCF was cross-linked to OCIM1, human serum-derived, or recombinant soluble c-kit receptor, a radiolabeled complex of -116 kD was found (data not shown). After subtracting the 18-kD contribution of "'I-SCF, the molecular weight of the OCIM1, human serumderived, and the recombinant soluble c-kit receptor is estimated to be 98 kD. In addition to the 116-kD band, affinity cross-linking to the recombinant soluble c-kit receptor shows a band at 245 kD, consistent with a dimer of the soluble ckit receptor (Fig 3) . Thus, the lower binding affinity of the recombinant soluble c-kit receptor cannot be explained by failure to dimerize in the presence of SCF.
Biosynthesis of the c-kit receptor. The time course of production of c-kit receptor protein was determined by biosynthetic labeling and immunoprecipitation with the SR-l antibody (Fig 4) . Two c-kit receptor proteins of molecular weight -120 kD and -130 kD are detected in the OCIM 1 cell lysates after l hour of biosynthetic labeling (time 0 Fig  4A) . Two hours after biosynthetic labeling, the 120-kD c-kit protein was no longer detectable. The 130-kD c-kit protein, consistent with the size of the transmembrane c-kit receptor in OCIMl cells, increased in quantity until the 5-hour timepoint and then gradually declined. A smaller c-kit receptor protein (98 kD) consistent with the size of the soluble c-kit receptor was first detected in the cell conditioned media 5 1, 0 hours; lane 2, 0.5 hours; lane 3, 1 hour; lane 4, 2 hours; lane 5, 5 hours; lane 6, 10.5 hours; lane 7, 22 hours; and  lane 8,30 hours. (B) Lane 1.0 hours; lane 2 , 5 hours; lane 3,lO hours; lane 4,22 hours; lane 5,30 hours; and lane 6,30 hours control. hours after biosynthetic labeling (Fig 4B) . The quantity of the soluble c-kit receptor protein increased over the next 25 hours. The 98-kD band was not present when the immunoprecipitation was performed with the control antibody ( Fig  4B, lane 6) .
Biologic activity of the recombinant soluble c-kit receptor. The OCIM1, human serum-derived, and recombinant soluble c-kit receptors were tested for the ability to block binding of '*'I-SCF to OCIMl cells (Table 3) 
DISCUSSION
We have identified a soluble form of the c-kit receptor produced by two human hematopoietic cell lines and have characterized the native form and a recombinant form of the soluble c-kit receptor in terms of molecular weight, SCF binding affinity, and ability to compete with transmembrane c-kit receptors on OClMl cells. Our results show that soluble c-kit receptors are produced in high quantity by the OCIM1, M07e, and HEL cell lines. Soluble c-kit receptor was detected in media conditioned by the cell lines as early as 24 hours: by 96 hours, the quantity of soluble c-kit receptors produced per cell was equivalent to the total quantity of receptors found on the cell surface. Affinity cross-linking The cause of the different binding affinity of the native human soluble c-kit receptors and the recombinant soluble receptor is unknown. The purification process itself did not alter binding affinity of the OCIMl or recombinant soluble c-kit receptor. It is known that different isoforms of the ckit receptor exist and that normal cells, fresh leukemic cells and hematopoietic cell lines contain mRNA for both isoforms.*' The recombinant soluble receptor consists of the kit A+ isoform only. It is possible that the kit A form, which is the predominant isoform produced in leukemic cell lines, may exhibit a higher binding affinity than the kit A+ isoform. However, the kd for the OCIMl soluble c-kit receptor was the same when receptor-ligand complexes were precipitated with the no. 1855 antibody, which recognizes the A+ carboxyterminus, or with the no. 951-960 antibody, which recognizes the entire extracellular domain of the receptor. Identification of the amino and carboxy termini of the native soluble c-kit receptor is presently underway and may identify important differences between the native and recombinant c-kit receptors.
All Soluble forms of cell surface receptors are generally produced either by alternative splicing of mRNA or by proteolytic cleavage of the transmembrane receptor at the junction of the extracellular domain and the transmembrane domain. 33 As stated above, two normal isoforms of the c-kit receptor have been r e p~r t e d l~*~~; these differ only by a 4 amino acid insertion within the extracellular domain, and both isoforms are expressed in erythroleukemia cell line^.'^^^^ Yee et reported the release of a 100-kD protein from murine mast cells that they suggest is the extracellular domain of the ckit receptor formed by proteolytic cleavage of the transmembrane c-kit receptor. Our 35S-methionine and 35S-cysteine pulse-chase experiments support the hypothesis that the soluble c-kit receptor is produced by posttranslational processing of the full-length transmembrane c-kit receptor. Although two cell-associated c-kit receptor proteins of molecular weight 120 kD and 130 kD are initially seen after 1 hour of biosynthetic labeling of OCIMl cells, the 120-kD protein is converted into the 130-kD species over the next 2 hours, consistent with a prior report.35 After 2 hours, all the labeled c-kit protein is represented in the 130-kD band. The 98-kD soluble c-kit receptor is not present in the cell lysates, does not appear in the cell supernatant until 5 hours after pulse labeling, and continues to increase in quantity up to 30 hours. These data suggest that the soluble receptor is generated by cleavage of the 130-kD transmembrane c-kit receptor. As noted above, amino acid sequence analysis of the carboxy terminus of the native soluble c-kit receptor may be required to identify the proteolytic cleavage site.
The biologic significance of naturally occurring soluble c-kit receptors is presently unknown. Possible roles for the soluble c-kit receptor include altering the half life of circulating SCF and modification of SCF-induced receptor activation. The ratio of soluble c-kit receptor to SCF may locally affect the bioactivity of SCF in vivo. The quantity of soluble c-kit receptor in human serum (320 ng/mL)" exceeds the quantity of soluble SCF (3 n g /~n L )~~ by a 30-fold molar excess, suggesting that sufficient amounts of soluble c-kit receptor are present in vivo to modulate SCF bioactivity. Soluble cytokine receptors may have clinical applications. The soluble IL-2 receptor can be used to monitor graft rejection in solid organ transplant^^^ or to monitor disease progression from asymptomatic human immunodeficiency virus to acquired immunodeficiency syndr0me.3~ Phase I1 trials investigating the use of soluble IL-1 receptors for the treatment of systemic inflammatory response syndrome are presently under~ay.~' Because of their small size and lack of antigenic potential, soluble receptors may have a clinical advantage as receptor antagonists over antiligand or antireceptor monoclonal antibodies.' Our data suggest that the soluble c-kit receptor can act as a receptor antagonist and therefore may play an important role in SCFlc-kit interactions.
